Our GLP-1 Weight Loss Pathway is designed specifically for individuals looking to shed pounds effectively, safely, and sustainably
The Research Backs It Up Science shows that structured programs using meal replacements often lead to better results than just trying to eat less. It creates a repeatable pattern
Lancet 2021;397:97184.ArticlePubMed 48
In this Analysis, we searched for relevant literature on the effects of GLP-1RAs across a range of illnesses, gathering and describing the available pre-clinical and mechanistic (278 studies) and clinical (96 studies) evidence for cognitive disorders, substance-use disorders, psychotic disorders, mood and anxiety disorders, eating disorders, and others
More important than net weight loss are changes in body compositionspecifically, reducing body fat while minimizing the loss of lean muscle mass
In contrast, apitegromab and trevogrumab target pro-MSTN and the latent complex, which helps minimize such side effects.[75,76] An additional noteworthy finding from studies on these two antibodies is that they not only increased muscle mass but also reduced fat mass.[75,76] This supports the notion that comprehensive MSTN inhibition, from its inactive forms to the mature form, represents a promising strategy for treating muscle loss in conjunction with metabolic disorders (Fig